Condition: Hypogammaglobulinemia · Multiple Sclerosis · Fatigue · Sponsor: Insel Gruppe AG, University Hospital Bern
The investigators hypothesize that hypogammaglobulinemia (defined as IgG serum concentration \<7.0g/L) is a treatable cause of fatigue in people with MS: The primary objective is to prove the link between hypogammaglobulinemia and fatigue in patients with multiple sclerosis. The secondary objective is to show that fatigue is mediated via frequent infections in people with MS and hypogammaglobulinemia.
This description comes directly from the study's public registry record.
Lara Diem, MD · 0041316327000 · larafrancesca.diem@insel.ch
Always discuss trial participation with your own doctor first.
| University Hospital of Bern Inselspital | Bern, Canton of Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05357781